Your browser doesn't support javascript.
loading
Quantification of urinary derivatives of Phenylbutyric and Benzoic acids by LC-MS/MS as treatment compliance biomarkers in Urea Cycle disorders.
Andrade, Fernando; Vitoria, Isidro; Martín Hernández, Elena; Pintos-Morell, Guillem; Correcher, Patricia; Puig-Piña, Rocío; Quijada-Fraile, Pilar; Peña-Quintana, Luis; Marquez, Ana Mª; Villate, Olatz; García Silva, Mª Teresa; de Las Heras, Javier; Ceberio, Leticia; Rodrigues, Esmeralda; Almeida Campos, Teresa; Yahyaoui, Raquel; Blasco, Javier; Vives-Piñera, Inmaculada; Gil, David; Del Toro, Mireia; Ruiz-Pons, Mónica; Cañedo, Elvira; Barba Romero, Miguel Angel; García-Jiménez, Mª Concepción; Aldámiz-Echevarría, Luis.
Afiliação
  • Andrade F; Group of Metabolism, Biocruces Bizkaia Health Research Institute, linked clinical group of Rare Diseases CIBER (CIBERER), Barakaldo, Spain.
  • Vitoria I; Unit of Metabolopathies, La Fe University Hospital, Valencia, Spain.
  • Martín Hernández E; Pediatric Rare Diseases Unit, Metabolic and Mitochondrial Diseases, Pediatric Department, 12 de Octubre University Hospital, Research Institute (i+12), Madrid, Spain.
  • Pintos-Morell G; Centre for Rare Diseases, University Hospital Vall d´Hebron, Barcelona. Research Institute Germans Trias I Pujol (IGTP), CIBERER-GCV08, Universitat Autònoma de Barcelona, Badalona, Spain.
  • Correcher P; Unit of Metabolopathies, La Fe University Hospital, Valencia, Spain.
  • Puig-Piña R; Department of Endocrinology and Nutrition. Adult Metabolic Unit. University Hospital Germans Trias i Pujol, Badalona, Spain.
  • Quijada-Fraile P; Pediatric Rare Diseases Unit, Metabolic and Mitochondrial Diseases, Pediatric Department, 12 de Octubre University Hospital, Research Institute (i+12), Madrid, Spain.
  • Peña-Quintana L; Pediatric Gastroenterology, Hepatology and Nutrition Unit, Mother-Child University Hospital of Canarias, Ciber OBN, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.
  • Marquez AM; Pediatric Gastroenterology and Nutrition Unit, Mother-Child Hospital of Badajoz, Spain.
  • Villate O; Group of Metabolism, Biocruces Bizkaia Health Research Institute, linked clinical group of Rare Diseases CIBER (CIBERER), Barakaldo, Spain.
  • García Silva MT; Pediatric Rare Diseases Unit, Metabolic and Mitochondrial Diseases, Pediatric Department, 12 de Octubre University Hospital, Research Institute (i+12), Madrid, Spain.
  • de Las Heras J; Group of Metabolism, Biocruces Bizkaia Health Research Institute, linked clinical group of Rare Diseases CIBER (CIBERER), Barakaldo, Spain.
  • Ceberio L; Group of Metabolism, Biocruces Bizkaia Health Research Institute, linked clinical group of Rare Diseases CIBER (CIBERER), Barakaldo, Spain.
  • Rodrigues E; Department of Pediatrics, Centro Hospitalar de Sao Joáo, Porto, Portugal.
  • Almeida Campos T; Department of Pediatrics, Centro Hospitalar de Sao Joáo, Porto, Portugal.
  • Yahyaoui R; Inherited Metabolic Disease Laboratory, Institute of Biomedical Research in Málaga (IBIMA), Málaga Regional University Hospital, Málaga, Spain.
  • Blasco J; Gastroenterology, Hepatology and Child Nutrition Unit, Carlos Haya University Hospital, Málaga, Spain.
  • Vives-Piñera I; Gastroenterology Unit, Virgen de la Arrixaca University Hospital, Murcia, Spain.
  • Gil D; Gastroenterology Unit, Virgen de la Arrixaca University Hospital, Murcia, Spain.
  • Del Toro M; Pediatric Neurology Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Ruiz-Pons M; Pediatric Nutrition Unit, Nuestra Señora de la Candelaria University Hospital, Santa Cruz de Tenerife, Spain.
  • Cañedo E; Gastroenterology and Nutrition Unit, Niño Jesús University Hospital, Madrid, Spain.
  • Barba Romero MA; Department of Internal Medicine, Albacete University Hospital, Castilla-La Mancha University, Spain.
  • García-Jiménez MC; Metabolic diseases Unit, Miguel Servet University Hospital, Zaragoza, Spain.
  • Aldámiz-Echevarría L; Group of Metabolism, Biocruces Bizkaia Health Research Institute, linked clinical group of Rare Diseases CIBER (CIBERER), Barakaldo, Spain. Electronic address: luisjose.aldamiz-echevarazuara@osakidetza.eus.
J Pharm Biomed Anal ; 176: 112798, 2019 Nov 30.
Article em En | MEDLINE | ID: mdl-31394303
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenilbutiratos / Benzoatos / Monitoramento de Medicamentos / Distúrbios Congênitos do Ciclo da Ureia / Glutamina Tipo de estudo: Evaluation_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: J Pharm Biomed Anal Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenilbutiratos / Benzoatos / Monitoramento de Medicamentos / Distúrbios Congênitos do Ciclo da Ureia / Glutamina Tipo de estudo: Evaluation_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: J Pharm Biomed Anal Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha